Westpac Banking Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.12M | Sell |
253,485
-4,505
| -2% | -$120K | 0.49% | 41 |
|
|
2025
Q4 | $6.42M | Sell |
257,990
-4,886
| -2% | -$123K | 0.41% | 48 |
|
|
2025
Q3 | $6.7M | Buy |
262,876
+36,846
| +16% | +$909K | 0.42% | 57 |
|
|
2025
Q2 | $5.48M | Buy |
226,030
+35,422
| +19% | +$826K | 0.37% | 67 |
|
|
2025
Q1 | $4.83M | Buy |
190,608
+87,937
| +86% | +$2.3M | 0.36% | 69 |
|
|
2024
Q4 | $2.72M | Buy |
102,671
+28,473
| +38% | +$772K | 0.18% | 131 |
|
|
2024
Q3 | $2.15M | Buy |
74,198
+18,225
| +33% | +$532K | 0.14% | 157 |
|
|
2024
Q2 | $1.57M | Buy |
55,973
+2,946
| +6% | +$81.1K | 0.12% | 153 |
|
|
2024
Q1 | $1.47M | Sell |
53,027
-949
| -2% | -$26.3K | 0.11% | 176 |
|
|
2023
Q4 | $1.55M | Sell |
53,976
-40,616
| -43% | -$1.23M | 0.13% | 166 |
|
|
2023
Q3 | $3.14M | Buy |
94,592
+44,699
| +90% | +$1.58M | 0.23% | 99 |
|
|
2023
Q2 | $1.83M | Sell |
49,893
-998,441
| -95% | -$38.9M | 0.13% | 187 |
|
|
2023
Q1 | $42.8M | Buy |
1,048,334
+143,214
| +16% | +$6.19M | 0.58% | 22 |
|
|
2022
Q4 | $46.4M | Buy |
905,120
+182,817
| +25% | +$8.76M | 0.69% | 17 |
|
|
2022
Q3 | $31.6M | Sell |
722,303
-72,765
| -9% | -$3.54M | 0.48% | 30 |
|
|
2022
Q2 | $41.7M | Sell |
795,068
-35,485
| -4% | -$1.81M | 0.54% | 23 |
|
|
2022
Q1 | $43M | Buy |
830,553
+64,189
| +8% | +$3.33M | 0.49% | 27 |
|
|
2021
Q4 | $45.3M | Buy |
766,364
+104,043
| +16% | +$5.15M | 0.47% | 33 |
|
|
2021
Q3 | $28.5M | Sell |
662,321
-171,565
| -21% | -$7.6M | 0.3% | 72 |
|
|
2021
Q2 | $32.7M | Sell |
833,886
-17,659
| -2% | -$687K | 0.33% | 62 |
|
|
2021
Q1 | $30.9M | Buy |
851,545
+23,300
| +3% | +$827K | 0.34% | 65 |
|
|
2020
Q4 | $30.5M | Sell |
828,245
-15,955
| -2% | -$585K | 0.35% | 60 |
|
|
2020
Q3 | $29.4M | Buy |
844,200
+18,481
| +2% | +$648K | 0.4% | 49 |
|
|
2020
Q2 | $25.6M | Sell |
825,719
-160,178
| -16% | -$5.44M | 0.38% | 54 |
|
|
2020
Q1 | $30.5M | Buy |
985,897
+6,082
| +0.6% | +$207K | 0.53% | 25 |
|
|
2019
Q4 | $36.4M | Sell |
979,815
-8,612
| -0.9% | -$307K | 0.47% | 32 |
|
|
2019
Q3 | $33.7M | Sell |
988,427
-101,189
| -9% | -$3.68M | 0.47% | 36 |
|
|
2019
Q2 | $44.8M | Buy |
1,089,616
+124,375
| +13% | +$4.94M | 0.68% | 22 |
|
|
2019
Q1 | $38.9M | Buy |
965,241
+185,641
| +24% | +$7.43M | 0.64% | 29 |
|
|
2018
Q4 | $32.3M | Buy |
779,600
+84,287
| +12% | +$3.5M | 0.55% | 32 |
|
|
2018
Q3 | $29.1M | Buy |
695,313
+61,379
| +10% | +$2.36M | 0.5% | 39 |
|
|
2018
Q2 | $21.8M | Sell |
633,934
-73,569
| -10% | -$2.51M | 0.42% | 59 |
|
|
2018
Q1 | $23.8M | Buy |
707,503
+33,892
| +5% | +$1.17M | 0.48% | 49 |
|
|
2017
Q4 | $23.1M | Buy |
673,611
+29,550
| +5% | +$1.01M | 0.53% | 36 |
|
|
2017
Q3 | $21.8M | Buy |
644,061
+36,911
| +6% | +$1.19M | 0.48% | 42 |
|
|
2017
Q2 | $19.3M | Sell |
607,150
-681,218
| -53% | -$21.5M | 0.43% | 47 |
|
|
2017
Q1 | $41.8M | Buy |
1,288,368
+219,507
| +21% | +$6.92M | 0.34% | 72 |
|
|
2016
Q4 | $36.9M | Buy |
1,068,861
+46,864
| +5% | +$1.43M | 0.35% | 75 |
|
|
2016
Q3 | $32.8M | Sell |
1,021,997
-285,518
| -22% | -$9.55M | 0.35% | 64 |
|
|
2016
Q2 | $41.4M | Sell |
1,307,515
-150,811
| -10% | -$4.81M | 0.45% | 42 |
|
|
2016
Q1 | $41M | Sell |
1,458,326
-860,772
| -37% | -$24.6M | 0.45% | 41 |
|
|
2015
Q4 | $71M | Sell |
2,319,098
-61,636
| -3% | -$1.94M | 0.79% | 29 |
|
|
2015
Q3 | $70.9M | Buy |
2,380,734
+446,027
| +23% | +$14.3M | 0.78% | 25 |
|
|
2015
Q2 | $61.5M | Sell |
1,934,707
-226,247
| -10% | -$7.37M | 0.6% | 32 |
|
|
2015
Q1 | $81M | Buy |
2,160,954
+26,125
| +1% | +$831K | 0.7% | 28 |
|
|
2014
Q4 | $63.1M | Sell |
2,134,829
-156,308
| -7% | -$4.48M | 0.6% | 30 |
|
|
2014
Q3 | $64.3M | Sell |
2,291,137
-24,357
| -1% | -$684K | 0.63% | 31 |
|
|
2014
Q2 | $65.2M | Sell |
2,315,494
-158,425
| -6% | -$4.52M | 0.63% | 30 |
|
|
2014
Q1 | $75.4M | Buy |
2,473,919
+709,460
| +40% | +$21.2M | 0.8% | 32 |
|
|
2013
Q4 | $51.3M | Sell |
1,764,459
-42,610
| -2% | -$1.24M | 0.59% | 33 |
|
|
2013
Q3 | $49.2M | Sell |
1,807,069
-179,551
| -9% | -$4.89M | 0.62% | 33 |
|
|
2013
Q2 | $53.7M | Buy |
+1,986,620
| New | +$54.9M | 0.82% | 19 |
|
Other funds holding PFE
VCM
VPM
Westpac Banking Corp's PFE Position: Q1 2026 in Review
Westpac Banking Corp reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $120K and leaving 253,485 shares worth $7.12M. The position accounts for 0.49% of the portfolio, ranked #41.
Westpac Banking Corp first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $81M in Q1 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Westpac Banking Corp held 253,485 shares of Pfizer worth $7.12M as of Q1 2026.
- Westpac Banking Corp sold 4,505 Pfizer shares in Q1 2026, an estimated $120K.
- Pfizer made up 0.49% of Westpac Banking Corp's portfolio in Q1 2026, its #41 holding.
- Westpac Banking Corp first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Westpac Banking Corp's Pfizer position peaked at $81M in Q1 2015.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.